GIMBHI’s daily mental health update — 3/10/26

🧠 Cognito Therapeutics raises $105M for at-home neurostimulation Alzheimer’s platform (MobiHealthNews) — 03/05/26
TL;DR: Cognito Therapeutics closed a $105M Series C to advance its Spectris device, which uses light and sound stimulation to treat Alzheimer’s at home.

🏥 Universal Health Services to acquire Talkspace for $835M to expand behavioral health (Yahoo Finance) — 03/09/26
TL;DR: UHS is buying Talkspace for $835M to access its 6,000-clinician network and build a full continuum of behavioral health services across inpatient and virtual care.

😴 South Korean sleep-tech startup Resol raises $2.1M Series A2 to expand globally (Seoul Economic Daily) — 03/10/26
TL;DR: Busan-based Resol secured $2.1M led by BNK Venture Capital to grow its brainwave entrainment wearable and sleep app internationally.

📈 Behavioral health startups are entering a funding renaissance after years of drought (Behavioral Health Business) — 03/05/26
TL;DR: After a post-COVID funding bust, 2026 is seeing major behavioral health investments shift toward niche markets, interventional psychiatry, and consolidation plays.

💰 Grow Therapy hits $3B valuation with $150M Series D led by TCV and Goldman Sachs (Bloomberg) — 03/03/26
TL;DR: Grow Therapy raised $150M Series D to scale its insurance-covered therapist and psychiatrist marketplace, reaching a $3B valuation.

🧒 Children’s Mercy surpasses $150M fundraising goal for pediatric mental health two years early (Children’s Mercy) — 03/02/26
TL;DR: Children’s Mercy’s Illuminate campaign hit its $150M goal ahead of schedule, funding 14 new initiatives to expand youth mental health access in Kansas City.